This coagulation treatment supports the relevance of other coagulation factors not included in prothrombin complex concentrates and fibrinogen to treat bleeding in massive hemorrhage which might affect 4–6% of patients with trauma-induced coagulopathy [36, 37]. The gene discussed is F2; the disease is blood coagulation disease.